AzTrials
AzTrials

OsteoarthritisNCT02494544

A Multicenter Study to Evaluate Functional Outcome After Knee Replacement

A study testing Off the Shelf Total Knee Replacement and ConforMIS iTotal Knee Replacement in people with Osteoarthritis, run by Restor3D at 8 sites in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Patients will be consecutively enrolled by implant. Implant groups will be those who have undergone surgery with either a ConforMIS iTotal® CR TKA or an Off-the- Shelf (OTS) system. The patient will conduct functional testing and answer questionnaires. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Osteoarthritis
What is being tested?
Off the Shelf Total Knee Replacement and ConforMIS iTotal Knee Replacement
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
215 participants
Where
8 sitesUnited States
Study dates
1 Jul 2015to 16 Nov 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Clinical condition included in the approved Indications For Use for the iTotal CR
  • Osteoarthritis, as confirmed by the investigator's assessment of disease status at screening visit that warrants a TKR procedure. Disease status is assessed by Clinical and Radiographic assessment
  • Willingness to participate in the clinical study, to give informed consent and to attend all follow-up visits
  • > 18 years of age

Who cannot join

  • Subject will require a simultaneous bilateral procedure
  • Other lower extremity surgery within 1 year
  • Severe (> 15º) fixed valgus or varus deformity
  • Severe (> 15º) extension deficit
  • Severe instability due to advanced loss of osteochondral structure
  • Loss of bone or musculature, osteoporosis, neuromuscular or vascular compromise in the area of the joint to be operated on to an extent that the procedure is unjustified
Show all 19Show fewer
  • Insufficient bone stock on the femoral or tibial surfaces
  • Contralateral knee replacement surgery within the past 6 months
  • BMI > 40
  • Active malignancy (defined as a history of any invasive malignancy - except non-melanoma skin cancer), unless patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years
  • Poorly controlled diabetes (defined as HbA1c >7 or surgeon discretion)
  • Immunocompromised
  • Other physical disability affecting the hips, spine, or contralateral knee that limits function
  • Disabling chronic pain with narcotic dependence
  • Compromised PCL or collateral ligament
  • Prior history of failed implant surgery of the joint to be treated, including Unicompartmental Knee Arthroplasty (UKA), or Bicompartmental Knee Arthroplasty (BKA)
  • Prior history of failed high tibial osteotomy (HTO)
  • Participation in another clinical study which would confound results
  • Inability to complete the protocol in the opinion of the clinical staff due to safety or other reasons

Trial locations and contacts

8 sites in 1 country.

8 sites in 1 country

United States8 sites
  • OrthoNY

    Albany, New York, 12205

  • Tufts University

    Boston, Massachusetts, 02111

  • The Lindner Center for Research and Education

    Cincinnati, Ohio, 45219

  • University of Missouri

    Columbia, Missouri, 65212

  • University of California in San Diego

    La Jolla, California, 92037

  • Yale School of Medicine

    New Haven, Connecticut, 06520

  • Denver-Vail Orthopedics

    Parker, Colorado, 80134

  • Sharp Healthcare

    San Diego, California, 92123

Other trials in United States

About this study

Official title: A Prospective, Multicenter Study to Evaluate Functional Outcome After Knee Replacement

Patients will be consecutively enrolled by implant. Implant groups will be those who have undergone surgery with either a ConforMIS iTotal® CR TKA or an Off-the- Shelf (OTS) system.

The patient will conduct functional testing and answer questionnaires.

The results will compare the ConforMIS iTotal with an Off the Shelf Knee replacement.

Read the detailed description

To compare functional and patient reported outcome data for a consecutively enrolled group of subjects who have undergone surgery with either a ConforMIS iTotal® CR TKA or an Off-the- Shelf (OTS) system.The person conducting the functional testing will be blinded to the device implanted. Sites will perform the off-the-shelf total knees conventional instrumentation.

Conditions
Osteoarthritis
Being tested
Off the Shelf Total Knee Replacement, ConforMIS iTotal Knee Replacement
Keywords
knee implant, knee replacement, total knee replacement
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Off the Shelf Total Knee ReplacementDevice

    A knee replacement system by DePuy, Zimmer, Biomet, Smith \& Nephew, or Stryker

  • ConforMIS iTotal Knee ReplacementDevice

    A knee replacement performed with patient specific implant and surgical jigs.

Study groups in NCT02494544
Study groupRoleWhat they receive
ConforMIS iTotal Knee replacementActive comparatoriTotal patient-specific knee replacement system
Receives: Device: ConforMIS iTotal Knee Replacement
DePuy total knee replacementActive comparatorOff the shelf knee replacement system
Receives: Device: Off the Shelf Total Knee Replacement
Zimmer total knee replacementActive comparatorOff the shelf knee replacement system
Receives: Device: Off the Shelf Total Knee Replacement
Biomet total knee replacementActive comparatorOff the shelf knee replacement system
Receives: Device: Off the Shelf Total Knee Replacement
Smith & Nephew total knee replacementActive comparatorOff the shelf knee replacement system
Receives: Device: Off the Shelf Total Knee Replacement
Stryker total knee replacementActive comparatorOff the shelf knee replacement system
Receives: Device: Off the Shelf Total Knee Replacement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Activities Subscale Score Within the Knee Society Score (KSS) Measure

    Comparing the functional testing differences between iTotal and off the shelf. "Total Functional Activities Score" - a subscale within the Knee Society Score (KSS) with its individual subscale score. The Total Functional Activities Score subscale interprets the functional knee health of each patient via a series of tests such as walking/standing (30 points), standard activities (30 points), advanced activities (25 points), and sports/recreational activities (15 points). Deductions to score are made for factors that limit a patient's mobility, such as needing to use an ambulatory device. The subscale scoring system ranges from 0-100, with higher scores indicating better knee function.

    Measured: 1 year

Secondary outcomes (2)
  1. Patient Satisfaction Subscale Score Within the Knee Society Score (KSS) Measure

    Measuring and comparing the differences between iTotal and off the shelf knees with patient reported outcomes. "Patient Satisfaction", a subscale within the Knee Society Score (KSS), was utilized to capture this metric. The Patient Satisfaction subscale combines scores given for certain responses (very satisfied, satisfied, neutral, somewhat dissatisfied, very dissatisfied) across 5 questions. These questions are designed to determine the level of satisfaction a patient has with their implant across both everyday and active activities. This score ranges from 0-40, with higher scores indicating higher levels of patient satisfaction.

    Measured: 1 year

  2. Incidents of Major Procedure-related and Device Related Complications (Including Revision Rates)

    All complications were stratified according to clinicaltrials.gov reporting standards and each site labeled each complication as either device-related, non-device-related, procedure-related, and non-procedure-related.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2015 (estimated)
  2. Study start1 Jul 2015
  3. Primary completion16 Nov 2022
  4. Study completion16 Nov 2022

Why it stopped: Decision of investigational team

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Sequential
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
215 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02494544
Sponsor's protocol ID
12-005
Status last verified
Nov 2025
First submitted
28 May 2015
Last updated
21 Nov 2025
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Off the Shelf Total Knee Replacement and ConforMIS iTotal Knee Replacement in people with Osteoarthritis, run by Restor3D at 8 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 21 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 Oct 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Activities Subscale Score Within the Knee Society Score (KSS) Measure (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02494544 | AzTrials